Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Monoclonal immunoglobulins]

J C Brouet

    Annales De Medecine Interne
    |January 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    This review covers Waldenström's macroglobulinemia, exploring its familial occurrence, distinguishing features from benign monoclonal IgM, and associated diseases. Understanding these aspects is crucial for accurate diagnosis and management of monoclonal immunoglobulins.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cerebro-meningeal localization of extramedullary haematopoiesis (EMH), a rare complication of chronic idiopathic myelofibrosis (CIM).

    Neuropathology and applied neurobiology·2004
    Same author

    Evaluation of bone mineral density and fat-lean distribution in patients with multiple myeloma in sustained remission.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2003
    Same author

    Interleukin-6 stimulates HHV-8 replication in bone marrow cultures and infected cell lines.

    The hematology journal : the official journal of the European Haematology Association·2002
    Same author

    [Chronic lymphoid leukemia].

    La Revue du praticien·2002
    Same author

    [A macroglobulinemia with an unusual bone marrow aspect].

    Annales de pathologie·2001
    Same author

    Study of the B cell memory compartment in common variable immunodeficiency.

    European journal of immunology·2000
    Same journal

    [Consensus Development Conference on Thrombosis and Pregnancy. 14 March 2003, Paris, France. Proceedings].

    Annales de medecine interne·2004
    Same journal

    Kartagener's syndrome and renal failure.

    Annales de medecine interne·2004
    Same journal

    Inflammatory pseudotumor of lymph nodes.

    Annales de medecine interne·2004
    Same journal

    [Necrolytic migratory erythema revealing glucagonoma without diabetes].

    Annales de medecine interne·2004
    Same journal

    [Bilateral primary non-Hodgkin's lymphomas of the adrenals].

    Annales de medecine interne·2004
    Same journal

    [Acute "pseudo-angiocholitis" due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis].

    Annales de medecine interne·2004
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Monoclonal immunoglobulins (Ig) are proteins produced by a single clone of plasma cells.
    • Waldenström's macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by monoclonal IgM.
    • Distinguishing WM from benign monoclonal gammopathies is clinically important.

    Discussion:

    • Familial occurrence of WM suggests a genetic predisposition.
    • Biologic features differentiating benign monoclonal IgM from WM include specific cellular markers and clinical presentation.
    • Numerous diseases are strongly associated with the presence of monoclonal Ig, indicating their potential role as biomarkers or pathogenic factors.

    Key Insights:

    • Genetic factors play a role in the development of Waldenström's macroglobulinemia.

    Related Experiment Videos

  • Careful evaluation of clinical and laboratory features is necessary to differentiate WM from benign monoclonal IgM.
  • Monoclonal Ig can be associated with a wide spectrum of clinical conditions.

    • Outlook:

    • Further research into the genetic basis of WM may reveal novel therapeutic targets.
    • Improved diagnostic criteria will enhance the early and accurate diagnosis of WM.
    • Understanding the association between monoclonal Ig and other diseases may lead to new diagnostic or therapeutic strategies.